Add To Watchlist
Share URL
Biotech Growth Ord
BIOG.L: LSELowest reading is at 18 out of 100. All scores are out of 100.
In Short
About The Company
Market Cap
292.33 Million GBp
Last Update
27/09/2026, 17:51:41
Description
.
Read More
Strongest readings
- ✔Debt is low at 0.04 times equity
Weakest readings
- ✘Income is not covering expenditure and investment (free cashflow -0.26 per share)
- ✘Priced well above the cashflow it produces (value score 18 out of 100)
- ✘Earnings and cashflow growth is weak (growth score 20 out of 100)
- ✘The current price sits above estimated fair value (margin of safety -3.56%)
Key Figures
| Status | Metric | Value | Reading | Market avg |
|---|---|---|---|---|
Price / earnings (TTM) | N/A | 19.60x | ||
| ✘ | Margin of safety (DCF) | -3.56% | 17.95% | |
| ✘ | Revenue growth (5y average) | 0.00% | 10.97% | |
| ✘ | Dividend yield (TTM) | 0.00% | 1.85% | |
Share count, per year | N/A | 0.00% | ||
| Return on capital employed | N/A | 10.00% |
The bar shows how good a reading is, so a longer bar is always better. The tick marks the benchmark.
Valuation
18 / 100Priced above the market on most measures.
| Status | Metric | Value | Reading | Market avg |
|---|---|---|---|---|
Price / earnings | N/A | 19.60x | ||
| ✘ | Free cashflow yield | -1.65% | 4.70% | |
| Price / earnings growth | N/A | 1.50x | ||
| Price / book | 103.69x | — | ||
| ✘ | Margin of safety | -3.56% | 17.95% |
The bar shows how good a reading is, so a longer bar is always better. The tick marks the benchmark.
- ✘Estimated intrinsic value of 1.49 Thousand GBp is below the current price of 1.55 Thousand GBp
Desired Margin Of Safety
0%
▼
Tip: Set your desired Margin Of Safety
Free Cash Flow Type
Annual Cashflow Growth
0%
Discount Rate
0%
Estimated Fair Value: 14.9 GBp ✘
Current Price: 1548 GBp
How Does This Work?
Show Advanced Options
This calculator helps investors estimate the Intrinsic Value of a company based on the current value of future cash flows. To use the tool, simply input a desired Margin Of Safety, which is an additional discount applied to the present value of the expected future cash flows. The tool calculates the present value using a discount rate that reflects the risk and time value of money, and provides an estimated fair value for the company based on the selected margin of safety. The calculator defaults to using 5 Year Free Cash Flow Growth % and a discount rate based on the US 10-year treasury bond coupon rate. Use our performance analyser to get a feel for the impact this has on longterm investment returns and find a margin of safety you are comfortable with.
Growth
20 / 100Growing more slowly than the market on most measures.
| Status | Metric | Value | Reading | Market avg |
|---|---|---|---|---|
| ✘ | Revenue growth | 0.00% | 10.97% | |
| Earnings growth | N/A | 14.48% | ||
| Cashflow growth | N/A | 12.35% |
The bar shows how good a reading is, so a longer bar is always better. The tick marks the benchmark.
Health
not enough dataNot enough of the underlying data is reported to score this section.
Measured on Leverage and capital, Funding and liquidity, Earnings quality.
| Status | Metric | Value | Reading | Threshold |
|---|---|---|---|---|
| ✔ | Debt / equity | 0.04x | 0.80x | |
| ✔ | Debt / total capital | 0.04x | 1.00x | |
| Equity / assets | 93.28% | — | ||
| ✘ | Debt / free cashflow | 0.00x | 0.15x | |
| Interest coverage | N/A | 2.50x |
The bar shows how good a reading is, so a longer bar is always better. The tick marks the benchmark.
- ✘Income is not covering expenditure and investment (free cashflow -0.26 per share)
Management
48 / 100Returns on capital are below the market.
| Status | Metric | Value | Reading | Market avg |
|---|---|---|---|---|
| ✘ | Return on equity | 11.55% | 15.00% | |
| Return on capital employed | N/A | 10.00% | ||
| Return on assets | 10.77% | — | ||
| Free cashflow return on capital | -0.41% | — | ||
| Return on capital, 5y change | N/A | 0.00% | ||
Share count, per year | N/A | 0.00% | ||
| Share count, recent | N/A | 0.00% | ||
| Realized buyback return | N/A | 0.00% | ||
| ✔ | Goodwill erosion / equity | 0.00% | 2.00% | |
| Price volatility, 5 year | 26.52% | — |
The bar shows how good a reading is, so a longer bar is always better. The tick marks the benchmark.
Analysts
not enough data| Status | Metric | Value | Reading | Neutral |
|---|---|---|---|---|
| Analyst opinion score | N/A | 50 |
The bar shows how good a reading is, so a longer bar is always better. The tick marks the benchmark.
Financial History
Annual figures across the full reporting history we hold.
Market Peers
BIOG.L
SEC Filings
Find yearly (10-K), quaterly (10-Q) and disclosure (8-K) report here, on the Securities and Exchange Commission's EDGAR database. If reading through reports isn't your cup of tea, don't worry. We've made it easy for you by summarizing all the important bits.
See 35+ Years Annual ReportsOther Information
Company Name
Biotech Growth Ord
Currency
GBp
Beta
Vol Avg
58603
Ceo
Cik
Cusip
Exchange
LSE
Full Time Employees
Industry
Sector
Ipo Date
Address
City
State
Country
Zip
Phone
Analysis Last Updated
27/09/2026, 17:51:41
Financial data compiled from SEC EDGAR filings and Yahoo Finance.